Ask the expert: Managing multiple conditions with Dr. Ramsay Fuleihan
PhRMA
We strive to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.
Merck
We aspire to be the premier research-intensive biopharmaceutical company. We’re at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.
PI diagnosis sparks PhD candidate’s neuroimmunology research interest
Adulting with PI support group leader specializes in trauma
Complement deficiencies
Decoding antibody deficiency diagnoses
Strategic Plan 2024-2026
Bill of Rights for individuals with primary immunodeficiencies

